Variable | Survival |
---|---|
Treatment (yes/no) | χ2 = 15.311, df = 1, P = 0.002* |
Age | r(63) = -0.028, P = 0.856 |
Breed | χ2 = 17.165, df = 4, P = 0.144 |
Sex | χ2 = 3.112, df = 3, P = 0.960 |
Lifestyle | χ2 = 0.889, df = 1, P = 0.889 |
Comorbidities (any) | χ2 = 0.381, df = 1, P = 0.944 |
Cutaneous clinical signs | χ2 = 1.693, df = 1, P = 0.638 |
Mucocutaneous clinical signs | χ2 = 3.100, df = 1, P = 0.377 |
Ocular clinical signs | χ2 = 3.742, df = 1, P = 0.291 |
Respiratory clinical signs | χ2 = 1.098, df = 1, P = 0.778 |
Systemic clinical signs | χ2 = 6.014, df = 1, P = 0.111 |
Anemia | χ2 = 0.669, df = 1, P = 0.881 |
Hyperproteinemia | χ2 = 1.048, df = 1, P = 0.790 |
Hyperglobulinemia | χ2 = 1.495, df = 1, P = 0.683 |
Hypergammaglobulinemia | χ2 = 2.252, df = 1, P = 0.522 |
Hypoalbuminemia | χ2 = 1.927, df = 1, P = 0.588 |
Azotemia | χ2 = 5.555, df = 1, P = 0.135 |
Proteinuria | χ2 = 2.233, df = 1, P = 0.526 |
PCR +ve  | χ2 = 9.932, df = 2, P = 0.128 |
Serological titer | χ2 = 18.920, df = 7, P = 0.590 |